Ruedi Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37
Closed -$3.33K 218
2025
Q1
$3.33K Hold
37
﹤0.01% 241
2024
Q4
$2.96K Hold
37
﹤0.01% 248
2024
Q3
$3.33K Hold
37
﹤0.01% 245
2024
Q2
$2.91K Hold
37
﹤0.01% 294
2024
Q1
$3.23K Hold
37
﹤0.01% 218
2023
Q4
$3.05K Buy
+37
New +$2.82K ﹤0.01% 195
2023
Q1
Sell
-74
Closed -$5.75K 275
2022
Q4
$5.75K Buy
+74
New +$6K ﹤0.01% 171

Other funds holding MDT

Ruedi Wealth Management's MDT Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Medtronic (MDT) in Q2 2025, closing a stake of 37 shares — an estimated $3.33K sold.

Ruedi Wealth Management first reported a position in MDT in Q4 2022 and held it in 7 quarters. The position peaked at $5.75K in Q4 2022. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 37 Medtronic shares in Q2 2025, an estimated $3.33K.
  • Ruedi Wealth Management first reported a position in Medtronic in Q4 2022 and held it in 7 quarters.
  • Ruedi Wealth Management's Medtronic position peaked at $5.75K in Q4 2022.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.